investing in this company has been disappointing not due to the business but due to this exit plan by management. their exit plan. seems like someones midlife crisis had a part to play here. it seems that the interests of retail shareholders that believed in this co were low in the order of considerations.
- Forums
- ASX - By Stock
- SLA
- Ann: SILK FY23 Results
Ann: SILK FY23 Results, page-9
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online